M. McNamara

570 total citations
28 papers, 439 citations indexed

About

M. McNamara is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, M. McNamara has authored 28 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in M. McNamara's work include Cancer therapeutics and mechanisms (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). M. McNamara is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). M. McNamara collaborates with scholars based in United States, United Kingdom and North Macedonia. M. McNamara's co-authors include Robert J. Morgan, George Somlo, James H. Doroshow, Paul Frankel, Dean Lim, Lucille Leong, David R. Gandara, Thehang Luu, Jana Portnow and David Smith and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Nature Chemistry.

In The Last Decade

M. McNamara

28 papers receiving 426 citations

Peers

M. McNamara

MB

ONCOL

CR

PRM

SURGE

Melissa Nelson United States

Minna Niemelä Finland

Gwo‐Yaw Ho Australia

Mihaela Popa Norway

Karianne G. Fleten Norway

María Loreto Bravo Chile

Kun Mi China

Lidan Zhu China

J. Catterall United Kingdom

Jon Chesebrough United States

Melissa Nelson United States

M. McNamara

185 ×0.7

MB

197 ×1.3

ONCOL

21 ×0.4

CR

53 ×1.2

PRM

24 ×0.6

SURGE

Citations per year, relative to M. McNamara M. McNamara (= 1×) peers Melissa Nelson

Countries citing papers authored by M. McNamara

Since Specialization

Citations

This map shows the geographic impact of M. McNamara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. McNamara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. McNamara more than expected).

Fields of papers citing papers by M. McNamara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. McNamara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. McNamara. The network helps show where M. McNamara may publish in the future.

Co-authorship network of co-authors of M. McNamara

This figure shows the co-authorship network connecting the top 25 collaborators of M. McNamara. A scholar is included among the top collaborators of M. McNamara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. McNamara. M. McNamara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Cooksley, Tim, Jamie Weaver, M. McNamara, & Paul Lorigan. (2024). Immune checkpoint inhibitor-related myasthenia gravis, myositis and myocarditis: a triad but not at the same time?. QJM. 117(5). 373–374. 3 indexed citations

2.

Commins, Patrick, Marieh B. Al‐Handawi, Rachid Rezgui, et al.. (2023). Autonomous and directional flow of water and transport of particles across a subliming dynamic crystal surface. Nature Chemistry. 15(5). 677–684. 13 indexed citations

3.

Graham, Kathryn, et al.. (2023). P-285 Basket trials in upper gastrointestinal and hepato-pancreatico-biliary cancers – an emerging entity. Annals of Oncology. 34. S116–S116. 2 indexed citations

4.

Commins, Patrick, et al.. (2022). Autonomous and Directional Flow of Water and Transport of Particles across a Subliming Dynamic Crystal Surface. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

5.

Pihlak, Rille, Melissa Frizziero, Sum Mak, et al.. (2020). P-274 RELEVANT study: Patient and physician perspectives on clinically-meaningful outcomes in advanced pancreatic ductal adenocarcinoma. Annals of Oncology. 31. S179–S179. 1 indexed citations

6.

Somlo, George, Cynthia L. Martel, Sean K. Lau, et al.. (2011). A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer. Breast Cancer Research and Treatment. 131(3). 899–906. 22 indexed citations

7.

Chao, Joseph, Timothy W. Synold, Robert J. Morgan, et al.. (2011). A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. Cancer Chemotherapy and Pharmacology. 69(3). 835–843. 36 indexed citations

8.

Cheung, Eric, Jacek Pinski, Tanya B. Dorff, et al.. (2009). Oral Fenretinide in Biochemically Recurrent Prostate Cancer: A California Cancer Consortium Phase II Trial. Clinical Genitourinary Cancer. 7(1). 43–50. 23 indexed citations

9.

Lai, Dominic W., et al.. (2009). The frequency of febrile neutropenia in oncology patients receiving chemotherapy. Journal of Clinical Oncology. 27(15_suppl). e20691–e20691. 1 indexed citations

10.

Reynolds, C. Patrick, Tomáš Frgala, Denice Tsao‐Wei, et al.. (2007). High plasma levels of fenretinide (4-HPR) were associated with improved outcome in a phase II study of recurrent ovarian cancer: A study by the California Cancer Consortium. Journal of Clinical Oncology. 25(18_suppl). 5555–5555. 14 indexed citations

11.

Luu, Thehang, L. Leong, Robert J. Morgan, et al.. (2007). Vorinostat (suberoylanilide hydroxamic acid) as salvage therapy in metastatic breast cancer (MBC): A California Cancer Consortium phase II study. Journal of Clinical Oncology. 25(18_suppl). 11502–11502. 3 indexed citations

12.

Margolin, Kim, James H. Doroshow, Paul Frankel, et al.. (2005). Paclitaxel-Based High-Dose Chemotherapy with Autologous Stem Cell Rescue for Relapsed Germ Cell Cancer. Biology of Blood and Marrow Transplantation. 11(11). 903–911. 17 indexed citations

13.

Springett, Gregory M., Chris H. Takimoto, M. McNamara, et al.. (2004). Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies. Journal of Clinical Oncology. 22(14_suppl). 3127–3127. 17 indexed citations

14.

Springett, Gregory M., Chris H. Takimoto, M. McNamara, et al.. (2004). Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies. Journal of Clinical Oncology. 22(14_suppl). 3127–3127. 10 indexed citations

15.

Shibata, Stephen, Richard D. Pezner, David Chu, et al.. (2004). A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies. European Journal of Surgical Oncology. 30(6). 650–657. 3 indexed citations

16.

Takimoto, Chris H., S. Syed, M. McNamara, et al.. (2004). 504 Phase I study of CT-2106 (polyglutamate camptothecin) in patients with advanced malignancies. European Journal of Cancer Supplements. 2(8). 154–154. 1 indexed citations

17.

Somlo, George, Jean F. Simpson, Paul Frankel, et al.. (2002). Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer. British Journal of Cancer. 87(3). 281–288. 22 indexed citations

18.

Morgan, R.J., L. Leong, J R Schriber, et al.. (2001). Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer. Bone Marrow Transplantation. 28(9). 859–863. 6 indexed citations

19.

Morgan, Robert J., Lucille Leong, Stephen Shibata, et al.. (2000). Phase II Trial of Combination Intraperitoneal Cisplatin and 5-Fluorouracil in Previously Treated Patients with Advanced Ovarian Cancer: Long-Term Follow-up. Gynecologic Oncology. 77(3). 433–438. 15 indexed citations

20.

Morgan, Robert J., Timothy W. Synold, Brian I. Carr, et al.. (2000). Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy. Cancer Chemotherapy and Pharmacology. 47(4). 327–332. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact